These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

782 related items for PubMed ID: 15317889

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. HIV-1 and HCV infections among antibody-negative blood donors.
    Laperche S, Pillonel J, Herve P.
    N Engl J Med; 2004 Nov 18; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559959
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R, Lelie N, Busch M, Kleinman S, International NAT Study Group.
    Transfusion; 2015 Jun 18; 55(6):1195-205. PubMed ID: 25727549
    [Abstract] [Full Text] [Related]

  • 26. Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing.
    O'Brien SF, Fan W, Scalia V, Goldman M, Fearon MA, Vamvakas EC.
    Vox Sang; 2006 Apr 18; 90(3):204. PubMed ID: 16507022
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M.
    J Clin Virol; 2007 Aug 18; 39(4):282-7. PubMed ID: 17611148
    [Abstract] [Full Text] [Related]

  • 29. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S, Elghouzzi MH, Morel P, Asso-Bonnet M, Le Marrec N, Girault A, Servant-Delmas A, Bouchardeau F, Deschaseaux M, Piquet Y.
    Transfusion; 2005 Dec 18; 45(12):1965-72. PubMed ID: 16371051
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
    Kretzschmar E, Chudy M, Nübling CM, Ross RS, Kruse F, Trobisch H.
    Vox Sang; 2007 May 18; 92(4):297-301. PubMed ID: 17456153
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.
    J Clin Virol; 2006 Jul 18; 36(3):166-76. PubMed ID: 16427802
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
    Brojer E, Gronowska A, Medyńska J, Grabarczyk P, Mikulska M, Letowska M, Kryczka W, Gietka A.
    Transfusion; 2004 Dec 18; 44(12):1706-10. PubMed ID: 15584984
    [Abstract] [Full Text] [Related]

  • 37. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G, Seed CR, Wang F, Nie D, Farrugia A.
    Transfusion; 2007 Mar 18; 47(3):529-39. PubMed ID: 17319836
    [Abstract] [Full Text] [Related]

  • 38. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
    Laperche S, Bouchardeau F, Maniez M, Béolet M, Elghouzzi MH, Lefrère JJ.
    Vox Sang; 2004 Apr 18; 86(3):198. PubMed ID: 15078255
    [No Abstract] [Full Text] [Related]

  • 39. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA, Strong DM, Tegtmeier GE, Holland PV, Kuramoto IK, Kemper M, Pietrelli L, Gallarda J.
    Transfusion; 2002 Nov 18; 42(11):1507-13. PubMed ID: 12421226
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F, Henriques I, Monteiro F, Meireles E, Cruz A, Tavares G, Mota-Miranda A.
    Transfus Clin Biol; 2005 Oct 18; 12(4):331-5. PubMed ID: 16182583
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.